Metraipolis › archive › dc_0c58ce7fb5bf
BOMT — Wikipedia (en)
- Source
- Wikipedia (en)
- Original
- https://en.wikipedia.org/wiki/BOMT
- License (as archived)
- CC-BY-SA-4.0
- Archived
- 2026-11-10T17:46:24.132Z
- SHA-256 of the archived text
5987f0a353c51bf91a5c320b911ba9469e5eb9428240afbce4c7d258deda53bd- Stable URL of this page
https://metraipolis.com/documento/dc_0c58ce7fb5bf
How to cite
BOMT — Wikipedia (en) — Wikipedia (en), https://en.wikipedia.org/wiki/BOMT (CC-BY-SA-4.0); archived copy: https://metraipolis.com/documento/dc_0c58ce7fb5bf (Metraipolis archive dc_0c58ce7fb5bf, sha256 5987f0a353c51bf91a5c320b911ba9469e5eb9428240afbce4c7d258deda53bd)
BibTeX
@misc{dc0c58ce7fb5bf,
title = {BOMT — Wikipedia (en)},
howpublished = {Wikipedia (en)},
url = {https://en.wikipedia.org/wiki/BOMT},
note = {License CC-BY-SA-4.0; archived copy https://metraipolis.com/documento/dc_0c58ce7fb5bf; sha256 5987f0a353c51bf91a5c320b911ba9469e5eb9428240afbce4c7d258deda53bd},
year = {2026}
}Archived text
Reproduced under CC-BY-SA-4.0. Attribution: Wikipedia (en), https://en.wikipedia.org/wiki/BOMT. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
BOMT, also known by its developmental code name Ro 7-2340 and as 6α-bromo-4-oxa-17α-methyl-5α-dihydrotestosterone, is a synthetic steroidal antiandrogen which was first produced in 1970 and was never marketed for medical use. It is the 6α-brominated, 4-oxygenated, and 17α-methylated derivative of the androgen dihydrotestosterone (DHT). Along with benorterone, cyproterone (and its C17α acetate ester, cyproterone acetate), and flutamide, BOMT was among the earliest antiandrogens to be developed and extensively studied, although it is less well-documented in comparison to the others. BOMT has been investigated clinically in the treatment of benign prostatic hyperplasia, though development for this use did not continue. There was also interest in BOMT for the potential applications of acne, pattern hair loss, and possibly prostate cancer, but it was not developed for these indications either. BOMT is a selective competitive antagonist of the androgen receptor (AR), although it is described as an "only relatively weak competitor." The relative binding affinity of the drug for the androgen receptor is about 2.7% of that of metribolone. BOMT shows no androgenic, estrogenic, or progestogenic activity even at high doses, nor any inhibition of 5α-reductase, though it has been reported to possess weak antigonadotropic effects. Due to its selectivity for and competitive inhibition of the AR, BOMT has been described as a pure or "true" antiandrogen, similarly to benorterone, cyproterone, and flutamide. Like other steroidal antiandrogens, BOMT may actually be a weak partial agonist of the AR, as it appears to have the potential for weak androgenic effects in specific situations. On the basis of animal research, BOMT does not appear to act as an AR antagonist in central nervous system tissues, and in relation to this, does not disinhibit the hypothalamic–pituitary–gonadal axis or increase testosterone levels. Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (deposito sistematico; retro-catalogo: tutte le voci di Wikipedia in inglese, in ordine alfabetico). Fonte: Wikipedia in inglese, voce «BOMT» — https://en.wikipedia.org/wiki/BOMT Wikidata Q28209089: «composto chimico» (dati Wikidata in CC0 1.0) — https://www.wikidata.org/wiki/Q28209089 Autori: i contributori di Wikipedia (cronologia: https://en.wikipedia.org/wiki/BOMT?action=history). Licenza: Creative Commons Attribuzione-Condividi allo stesso modo 4.0 (CC BY-SA 4.0) — https://creativecommons.org/licenses/by-sa/4.0/. Il riuso richiede attribuzione e stessa licenza. Estratto dell'introduzione non modificato nel contenuto; revisione 1329007852, consultata il 2026-11-10T17:43:34.361Z tramite l'API ufficiale di Wikipedia. Impronta SHA-256 dell'estratto: ad655e74e03594097892ecb0d7526b9e6ec6d179c8385506dc81130f80974f12